Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein by Small Molecules as a Potential Therapeutic Strategy for Parkinson’s Disease

α-Synuclein in Lewy bodies

Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382 · see citing works

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · see citing works

Protein Misfolding, Functional Amyloid, and Human Disease

Chiti, F., & Dobson, C. M. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.123901 · Cited by 6,435 · see citing works

Protein folding and misfolding

Dobson, C. M. (2003) · Nature · doi:10.1038/nature02261 · Cited by 4,791 · see citing works

Cox’s regression model for counting processes: A large sample study

Andersen, P. K., & Gill, R. D. (1982) · The Annals of Statistics · doi:10.1214/aos/1176345976 · Cited by 4,419 · see citing works

α-Synuclein Locus Triplication Causes Parkinson's Disease

Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383 · see citing works

Intrinsically unstructured proteins and their functions

Dyson, H. J., & Wright, P. E. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1589 · Cited by 3,871 · see citing works

DrugBank: a knowledgebase for drugs, drug actions and drug targets

Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., & Hassanali, M. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm958 · Cited by 2,852 · see citing works

The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia

Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737 · see citing works

A Hot Spot of Binding Energy in a Hormone-Receptor Interface

Clackson, T., & Wells, J. A. (1995) · Science · doi:10.1126/science.7529940 · Cited by 1,987 · see citing works

Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death

Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R., & Finkbeiner, S. (2004) · Nature · doi:10.1038/nature02998 · Cited by 1,979 · see citing works

Genome-wide association study reveals genetic risk underlying Parkinson's disease

Simón‐Sánchez, J., Schulte, C., Brás, J., Sharma, M., Gibbs, J. R., Berg, D., Paisán‐Ruiz, C., Lichtner, P., Scholz, S. W., Hernandez, D. G., et al. (2009) · Nature Genetics · doi:10.1038/ng.487 · Cited by 1,916 · see citing works

α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro

Burré, J., Sharma, M., Tsetsenis, T., Buchman, V. L., Etherton, M. R., & Südhof, T. C. (2010) · Science · doi:10.1126/science.1195227 · Cited by 1,817 · see citing works

Molecular Pathways of Neurodegeneration in Parkinson's Disease

Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,659 · see citing works

Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy

Conway, K. A., Lee, S., Rochet, J., Ding, T. T., Williamson, R. E., & Lansbury, P. T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.571 · Cited by 1,543 · see citing works

NACP, A Protein Implicated in Alzheimer's Disease and Learning, Is Natively Unfolded

Weinreb, P. H., Zhen, W., Poon, A. W., Conway, K. A., & Lansbury, P. T. (1996) · Biochemistry · doi:10.1021/bi961799n · Cited by 1,524 · see citing works

Association between Early-Onset Parkinson's Disease and Mutations in theParkinGene

Lücking, C. B., Dürr, A., Bonifati, V., Vaughan, J. R., Michele, G. D., Gasser, T., Harhangi, B. S., Meco, G., Denèfle, P., Wood, N. W., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005253422103 · Cited by 1,433 · see citing works

Phosphorylation of Ser-129 Is the Dominant Pathological Modification of α-Synuclein in Familial and Sporadic Lewy Body Disease

Anderson, J. P., Walker, D., Goldstein, J. M., de Laat, R., Banducci, K., Caccavello, R. J., Barbour, R., Huang, J., Kling, K., Lee, M., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600933200 · Cited by 1,418 · see citing works

α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models

Cooper, A. A., Gitler, A. D., Cashikar, A. G., Haynes, C. M., Hill, K. J., Bhullar, B., Liu, K., Xu, K., Strathearn, K. E., Liu, F., et al. (2006) · Science · doi:10.1126/science.1129462 · Cited by 1,377 · see citing works

Understanding protein non-folding

Uversky, V. N., & Dunker, A. K. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.01.017 · Cited by 1,188 · see citing works

Evidence for a Partially Folded Intermediate in α-Synuclein Fibril Formation

Uversky, V. N., Li, J., & Fink, A. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010907200 · Cited by 1,096 · see citing works

Sirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's Disease

Outeiro, T. F., Kontopoulos, E., Altmann, S. M., Kufareva, I., Strathearn, K. E., Amore, A. M., Volk, C. B., Maxwell, M. M., Rochet, J., McLean, P. J., et al. (2007) · Science · doi:10.1126/science.1143780 · Cited by 1,066 · see citing works

Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis

Nemani, V. M., Lü, W., Berge‐Seidl, V., Nakamura, K., Onoa, B., Lee, M. K., Chaudhry, F. A., Nicoll, R. A., & Edwards, R. H. (2010) · Neuron · doi:10.1016/j.neuron.2009.12.023 · Cited by 1,051 · see citing works

Synaptic Vesicle Depletion Correlates with Attenuated Synaptic Responses to Prolonged Repetitive Stimulation in Mice Lacking α-Synuclein

Cabin, D. E., Shimazu, K., Murphy, D., Cole, N. B., Gottschalk, W., McIlwain, K. L., Orrison, B., Chen, A., Ellis, C. E., Paylor, R., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08797.2002 · Cited by 865 · see citing works

Therapeutic approaches to protein-misfolding diseases

Cohen, F. E., & Kelly, J. W. (2003) · Nature · doi:10.1038/nature02265 · Cited by 792 · see citing works

Release of long-range tertiary interactions potentiates aggregation of natively unstructured α-synuclein

Bertoncini, C. W., Jung, Y., Fernández, C. O., Hoyer, W., Griesinger, C., Jovin, T. M., & Zweckstetter, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407146102 · Cited by 781 · see citing works

FRED Pose Prediction and Virtual Screening Accuracy

McGann, M. R. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci100436p · Cited by 772 · see citing works

Synucleins Are Developmentally Expressed, and α-Synuclein Regulates the Size of the Presynaptic Vesicular Pool in Primary Hippocampal Neurons

Murphy, D. D., Rueter, S. M., Trojanowski, J. Q., & Lee, V. M. ‐. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-09-03214.2000 · Cited by 753 · see citing works

Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade

Bulawa, C., Connelly, S., DeVit, M. J., Wang, L., Weigel, C., Fleming, J., Packman, J., Powers, E. T., Wiseman, R. L., Foss, T. R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121005109 · Cited by 750 · see citing works

Mapping Long-Range Interactions in α-Synuclein using Spin-Label NMR and Ensemble Molecular Dynamics Simulations

Dedmon, M. M., Lindorff‐Larsen, K., Christodoulou, J. C., Vendruscolo, M., & Dobson, C. M. (2004) · Journal of the American Chemical Society · doi:10.1021/ja044834j · Cited by 718 · see citing works

The interplay between structure and function in intrinsically unstructured proteins

Tompa, P. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.03.072 · Cited by 717 · see citing works

Direct Membrane Association Drives Mitochondrial Fission by the Parkinson Disease-associated Protein α-Synuclein*♦

Nakamura, K., Nemani, V., Azarbal, F., Skibinski, G., Levy, J. M., Egami, K., Munishkina, L. A., Zhang, J., Gardner, B. M., Wakabayashi, J., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.213538 · Cited by 590 · see citing works

Dependence of α-Synuclein Aggregate Morphology on Solution Conditions

Hoyer, W., Antony, T., Cherny, D., Heim, G., Jovin, T. M., & Subramaniam, V. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00775-1 · Cited by 553 · see citing works

α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity

Gitler, A. D., Chesi, A., Geddie, M. L., Strathearn, K. E., Hamamichi, S., Hill, K. J., Caldwell, K. A., Caldwell, G. A., Cooper, A. A., Rochet, J., et al. (2009) · Nature Genetics · doi:10.1038/ng.300 · Cited by 535 · see citing works

α-Synuclein: Membrane Interactions and Toxicity in Parkinson's Disease

Auluck, P. K., Caraveo, G., & Lindquist, S. L. (2010) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.042308.113313 · Cited by 516 · see citing works

Synaptic Vesicle ExocytosisPreprint

Südhof, T. C., & Rizo, J. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005637 · Cited by 502 · see citing works

Virtual screening strategies in drug discovery

McInnes, C. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.08.033 · Cited by 469 · see citing works

Double-knockout mice for α- and β-synucleins: Effect on synaptic functions

Chandra, S., Fornai, F., Kwon, H.-B., Yazdani, U., Atasoy, D., Liu, X., Hammer, R. E., Battaglia, G., German, D. C., Castillo, P. E., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406283101 · Cited by 438 · see citing works

Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication

Fuchs, J., Nilsson, C., Kachergus, J. M., Munz, M., Larsson, E., Schüle, B., Langston, J. W., Middleton, F. A., Ross, O. A., Hulihan, M., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000254458.17630.c5 · Cited by 397 · see citing works

Rational design of potent human transthyretin amyloid disease inhibitors.

Sacchettini, J. C., Klabunde, T., Petrassi, H. M., Oza, V. B., Raman, P., & Kelly, J. W. (2000) · Nature Structural Biology · doi:10.1038/74082 · Cited by 373 · see citing works

alpha-synuclein gene haplotypes are associated with Parkinson's disease

Farrer, M. J. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.17.1847 · Cited by 340 · see citing works

NMR Characterization of Long-Range Order in Intrinsically Disordered Proteins

Salmon, L., Nodet, G., Ozenne, V., Yin, G., Jensen, M. R., Zweckstetter, M., & Blackledge, M. J. (2010) · Journal of the American Chemical Society · doi:10.1021/ja101645g · Cited by 304 · see citing works

Intrinsically disordered proteins are potential drug targets

Metallo, S. J. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.06.169 · Cited by 298 · see citing works

α-Synuclein Delays Endoplasmic Reticulum (ER)-to-Golgi Transport in Mammalian Cells by Antagonizing ER/Golgi SNAREs

Thayanidhi, N., Helm, J. R., Nycz, D. C., Bentley, M., Liang, Y., & Hay, J. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-09-0801 · Cited by 229 · see citing works

Functional Alterations to the Nigrostriatal System in Mice Lacking All Three Members of the Synuclein Family

Anwar, S., Peters, O. M., Millership, S. J., Ninkina, N. N., Doig, N. M., Connor‐Robson, N., Threlfell, S., Kooner, G., Deacon, R. M. J., Bannerman, D. M., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6194-10.2011 · Cited by 200 · see citing works

Monomeric Synucleins Generate Membrane Curvature

Westphal, C. H., & Chandra, S. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.418871 · Cited by 199 · see citing works

Determination of the Free Energy Landscape of α-Synuclein Using Spin Label Nuclear Magnetic Resonance Measurements

Allison, J. R., Várnai, P., Dobson, C. M., & Vendruscolo, M. (2009) · Journal of the American Chemical Society · doi:10.1021/ja904716h · Cited by 197 · see citing works

Familial Mutants of α-Synuclein with Increased Neurotoxicity Have a Destabilized Conformation

Bertoncini, C. W., Fernández, C. O., Griesinger, C., Jovin, T. M., & Zweckstetter, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500288200 · Cited by 187 · see citing works

Quantitative Determination of the Conformational Properties of Partially Folded and Intrinsically Disordered Proteins Using NMR Dipolar Couplings

Jensen, M. R., Markwick, P. R. L., Meier, S., Griesinger, C., Zweckstetter, M., Grzesiek, S., Bernadó, P., & Blackledge, M. J. (2009) · Structure · doi:10.1016/j.str.2009.08.001 · Cited by 177 · see citing works

Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson’s disease models

Su, L. J., Auluck, P. K., Outeiro, T. F., Yeger‐Lotem, E., Kritzer, J. A., Tardiff, D. F., Strathearn, K. E., Liu, F., Cao, S., Hamamichi, S., et al. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.004267 · Cited by 176 · see citing works

α‐Synuclein and Polyunsaturated Fatty Acids Promote Clathrin‐Mediated Endocytosis and Synaptic Vesicle Recycling

Ben Gedalya, T., Loeb, V., Israeli, E., Altschuler, Y., Selkoe, D. J., & Sharon, R. (2009) · Traffic · doi:10.1111/j.1600-0854.2008.00853.x · Cited by 169 · see citing works

Endocytic pathway from the basal plasma membrane to the ruffled border membrane in bone-resorbing osteoclasts

Palokangas, H., Mulari, M. T. K., & Väänänen, H. K. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.15.1767 · Cited by 168 · see citing works

v-SNARE-dependent secretion is required for phagocytosis

Hackam, D. J., Rotstein, O. D., Sjölin, C., Schreiber, A. D., Trimble, W. S., & Grinstein, S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11691 · Cited by 153 · see citing works

Nigrostriatal overabundance of α-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity

Gaugler, M. N. M., Genç, Ö., Bobela, W., Mohanna, S., Ardah, M. T., El‐Agnaf, O. M. A., Cantoni, M., Bensadoun, J., Schneggenburger, R., Knott, G. W., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0963-y · Cited by 150 · see citing works

Review: Familial Parkinson's disease – genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease

Schiesling, C., Kieper, N., Seidel, K., & Krüger, R. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00952.x · Cited by 135 · see citing works

Identification of Hot Spots within Druggable Binding Regions by Computational Solvent Mapping of Proteins

Landon, M. R., Lancia, D. R., Yu, J., Thiel, S., & Vajda, S. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061134b · Cited by 133 · see citing works

Determination of conformationally heterogeneous states of proteins

Vendruscolo, M. (2007) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2007.01.002 · Cited by 132 · see citing works

Elevated Alpha-Synuclein Impairs Innate Immune Cell Function and Provides a Potential Peripheral Biomarker for Parkinson's Disease

Gardai, S. J., Mao, W., Schüle, B., Babcock, M., Schoebel, S., Lorenzana, C., Alexander, J., Kim, S., Glick, H., Hilton, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071634 · Cited by 107 · see citing works

Mechanisms of DJ‐1 neuroprotection in a cellular model of Parkinson’s disease

Liu, F., Nguyen, J. L., Hulleman, J. D., Li, L., & Rochet, J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05333.x · Cited by 98 · see citing works

On the Mechanism of Nonspecific Inhibitors of Protein Aggregation: Dissecting the Interactions of α-Synuclein with Congo Red and Lacmoid

Lendel, C., Bertoncini, C. W., Cremades, N., Waudby, C. A., Vendruscolo, M., Dobson, C. M., Schenk, D., Christodoulou, J. C., & Tóth, G. (2009) · Biochemistry · doi:10.1021/bi901285x · Cited by 97 · see citing works

Small Molecule Microarrays Enable the Discovery of Compounds That Bind the Alzheimer’s Aβ Peptide and Reduce its Cytotoxicity

Chen, J., Armstrong, A. H., Koehler, A. N., & Hecht, M. H. (2010) · Journal of the American Chemical Society · doi:10.1021/ja107552s · Cited by 89 · see citing works

Identification of small-molecule binding pockets in the soluble monomeric form of the Aβ42 peptide

Zhu, M., Simone, A. D., Schenk, D., Tóth, G., Dobson, C. M., & Vendruscolo, M. (2013) · The Journal of Chemical Physics · doi:10.1063/1.4811831 · Cited by 83 · see citing works

Molecular pathogenesis of Parkinson's disease: update

Saiki, S., Sato, S., & Hattori, N. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301205 · Cited by 80 · see citing works

Algorithms for computational solvent mapping of proteins

Körtvélyesi, T., Dennis, S., Silberstein, M., Brown, L., & Vajda, S. (2003) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.10287 · Cited by 57 · see citing works

High-Throughput Screening in Primary Neurons

Sharma, P., Ando, D., Daub, A. C., Kaye, J. A., & Finkbeiner, S. (2012) · Methods in Enzymology · doi:10.1016/b978-0-12-391856-7.00041-x · Cited by 46 · see citing works

Regulation of Weibel-Palade Body Exocytosis by α-Synuclein in Endothelial Cells

Kim, K. S., Park, J., Jou, I., & Park, S. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.103499 · Cited by 38 · see citing works

Binding of 3,4,5,6-Tetrahydroxyazepanes to the Acid-β-glucosidase Active Site: Implications for Pharmacological Chaperone Design for Gaucher Disease

Orwig, S. D., Tan, Y. L., Grimster, N. P., Yu, Z., Powers, E. T., Kelly, J. W., & Lieberman, R. L. (2011) · Biochemistry · doi:10.1021/bi201619z · Cited by 37 · see citing works

Regulation of Weibel-Palade Body Exocytosis by alpha-Synuclein in Endothelial Cells

김, 광. (2011) · Cited by 21 · see citing works

Molecular cloning, genomic organization, chromosomal mapping and subcellular localization of mouse PAP7: a PBR and PKA-RIα associated protein

Liu, J., Cavalli, L. R., Haddad, B. R., & Papadopoulos, V. (2003) · Gene · doi:10.1016/s0378-1119(03)00453-0 · Cited by 18 · see citing works

The amyloid state and its association with protein misfolding diseases.

Knowles, T. P. J., Vendruscolo, M., & Dobson, C. M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3810 · Cited by 2,382 · see citing works

Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade

Savelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00138 · Cited by 603 · see citing works

Protein Ensembles: How Does Nature Harness Thermodynamic Fluctuations for Life? The Diverse Functional Roles of Conformational Ensembles in the Cell

Wei, G., Xi, W., Nussinov, R., & Ma, B. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00562 · Cited by 436 · see citing works

Historical Perspective: Models of Parkinson’s Disease

Chia, S. J., Tan, E., & Chao, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072464 · Cited by 410 · see citing works

Alpha-synuclein biology in Lewy body diseases

Kim, W. S., Kågedal, K., & Halliday, G. M. (2014) · Alzheimer s Research & Therapy · doi:10.1186/s13195-014-0073-2 · Cited by 376 · see citing works

A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity

Perni, M., Galvagnion, C., Maltsev, A. S., Meisl, G., Müller, M. B. D., Challa, P. K., Kirkegaard, J. B., Flagmeier, P., Cohen, S. I. A., Cascella, R., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610586114 · Cited by 296 · see citing works

The ongoing pursuit of neuroprotective therapies in Parkinson disease

Athauda, D. S., & Foltynie, T. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.226 · Cited by 267 · see citing works

Review: Parkinson's disease: from synaptic loss to connectome dysfunction

Bellucci, A., Mercuri, N. B., Venneri, A., Faustini, G., Longhena, F., Pizzi, M., Missale, C., & Spano, P. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12297 · Cited by 203 · see citing works

Is β-Catenin a Druggable Target for Cancer Therapy?

Cui, C., Zhou, X., Zhang, W., Qu, Y., & Ke, X. (2018) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.06.003 · Cited by 168 · see citing works

A de novo compound targeting α-synuclein improves deficits in models of Parkinson's disease

Wrasidlo, W., Tsigelny, I. F., Price, D. L., Dutta, G., Rockenstein, E. M., Schwarz, T. C., Ledolter, K., Bonhaus, D. W., Paulino, A., Eleuteri, S., et al. (2016) · Brain · doi:10.1093/brain/aww238 · Cited by 150 · see citing works

Defective synaptic connectivity and axonal neuropathology in a human iPSC-based model of familial Parkinson’s disease

Kouroupi, G., Taoufik, E., Vlachos, I. S., Tsioras, K., Antoniou, N., Papastefanaki, F., Chroni-Tzartou, D., Wrasidlo, W., Bohl, D., Stellas, D., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617259114 · Cited by 145 · see citing works

Molecular Basis of Small-Molecule Binding to α-Synuclein

Robustelli, P., de Opakua, A. I., Campbell-Bezat, C. K., Giordanetto, F., Becker, S., Zweckstetter, M., Pan, A. C., & Shaw, D. E. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.1c07591 · Cited by 131 · see citing works

Identification of a Drug Targeting an Intrinsically Disordered Protein Involved in Pancreatic Adenocarcinoma

Neira, J. L., Bintz, J., Arruebo, M. P., Rizzuti, B., Bonacci, T., Vega, S., Lanas, Á., Velázquez‐Campoy, A., Iovanna, J., & Abián, O. (2017) · Scientific Reports · doi:10.1038/srep39732 · Cited by 133 · see citing works

Finding Our Way in the Dark Proteome

Bhowmick, A., Brookes, D. H., Yost, S. R., Dyson, H. J., Forman-Kay, J. D., Gunter, D., Head-Gordon, M., Hura, G. L., Pande, V. S., Wemmer, D. E., et al. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b06543 · Cited by 128 · see citing works

Targeting intrinsically disordered proteins at the edge of chaos

Ruan, H., Sun, Q., Zhang, W., Liu, Y., & Lai, L. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2018.09.017 · Cited by 133 · see citing works

Intrinsically disordered proteins and biomolecular condensates as drug targets

Biesaga, M., Frigolé-Vivas, M., & Salvatella, X. (2021) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2021.02.009 · Cited by 115 · see citing works

Recent Developments in the Field of Intrinsically Disordered Proteins: Intrinsic Disorder–Based Emergence in Cellular Biology in Light of the Physiological and Pathological Liquid–Liquid Phase Transitions

Uversky, V. N. (2021) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-062920-063704 · Cited by 117 · see citing works

Structure-based Inhibitor Design for the Intrinsically Disordered Protein c-Myc

Chen, Y., Niu, X., Jin, F., Liu, Z., Jin, C., & Lai, L. (2016) · Scientific Reports · doi:10.1038/srep22298 · Cited by 115 · see citing works

Multistep Inhibition of α-Synuclein Aggregation and Toxicity in Vitro and in Vivo by Trodusquemine

Perni, M., Flagmeier, P., Limbocker, R., Cascella, R., Aprile, F. A., Galvagnion, C., Heller, G. T., Meisl, G., Chen, S. W., Kumita, J. R., et al. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00466 · Cited by 113 · see citing works

High-performance virtual screening by targeting a high-resolution RNA dynamic ensemble

Ganser, L. R., Lee, J. H., Rangadurai, A., Merriman, D. K., Kelly, M. L., Kansal, A. D., Sathyamoorthy, B., & Al‐Hashimi, H. M. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0062-4 · Cited by 112 · see citing works

Targeting disordered proteins with small molecules using entropy

Heller, G. T., Sormanni, P., & Vendruscolo, M. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.07.004 · Cited by 104 · see citing works

Targeting intrinsically disordered proteins in rational drug discovery

Ambadipudi, S., & Zweckstetter, M. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1107041 · Cited by 97 · see citing works

An intrinsically disordered region of methyl-CpG binding domain protein 2 (MBD2) recruits the histone deacetylase core of the NuRD complex

Desai, M., Webb, H., Sinanan, L. M., Scarsdale, J. N., Walavalkar, N. M., Ginder, G. D., & Williams, D. C. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv168 · Cited by 93 · see citing works

Discovery of Small Molecules that Inhibit the Disordered Protein, p27Kip1

Iconaru, L. I., Ban, D., Bharatham, K., Ramanathan, A., Zhang, W., Shelat, A. A., Zuo, J., & Kriwacki, R. W. (2015) · Scientific Reports · doi:10.1038/srep15686 · Cited by 91 · see citing works

Druggability of Intrinsically Disordered Proteins

Joshi, P., & Vendruscolo, M. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-20164-1_13 · Cited by 84 · see citing works

Potent α-Synuclein Aggregation Inhibitors, Identified by High-Throughput Screening, Mainly Target the Monomeric State

Kurnik, M., Sahin, C., Andersen, C. B., Lorenzen, N., Giehm, L., Mohammad‐Beigi, H., Jessen, C. M., Pedersen, J. S., Christiansen, G., Petersen, S. V., et al. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.08.005 · Cited by 78 · see citing works

Foldamer-mediated manipulation of a pre-amyloid toxin

Kumar, S., Birol, M., Schlamadinger, D. E., Wojcik, S. P., Rhoades, E. R., & Miranker, A. D. (2016) · Nature Communications · doi:10.1038/ncomms11412 · Cited by 80 · see citing works

Polyphenols in combination with β-cyclodextrin can inhibit and disaggregate α-synuclein amyloids under cell mimicking conditions: A promising therapeutic alternative

Gautam, S., Karmakar, S., Batra, R., Sharma, P. V., Pradhan, P. C., Singh, J., Kundu, B., & Chowdhury, P. K. (2017) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2017.02.014 · Cited by 74 · see citing works

Osteoporosis and alzheimer pathology: Role of cellular stress response and hormetic redox signaling in aging and bone remodeling

Cornelius, C., Koverech, G., Crupi, R., Paola, R. D., Koverech, A., Lodato, F., Scuto, M., Salinaro, A., Cuzzocrea, S., Calabrese, E., et al. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00120 · Cited by 70 · see citing works

An engineered monomer binding-protein for α-synuclein efficiently inhibits the proliferation of amyloid fibrils

Agerschou, E. D., Saridaki, T., Flagmeier, P., Galvagnion, C., Komnig, D., Nagpal, A., Gasterich, N., Heid, L. F., Prasad, V., Shaykhalishahi, H., et al. (2019) · eLife · doi:10.7554/elife.46112 · Cited by 71 · see citing works

Computer-Aided Drug Discovery for Undruggable Targets

Sun, Q., Wang, H., Xie, J., Wang, L., Mu, J., Li, J., Ren, Y., & Lai, L. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00969 · Cited by 69 · see citing works

A Relationship between the Transient Structure in the Monomeric State and the Aggregation Propensities of α-Synuclein and β-Synuclein

Allison, J. R., Rivers, R. C., Christodoulou, J., Vendruscolo, M., & Dobson, C. M. (2014) · Biochemistry · doi:10.1021/bi5009326 · Cited by 63 · see citing works

Sequence Specificity in the Entropy-Driven Binding of a Small Molecule and a Disordered Peptide

Heller, G. T., Aprile, F. A., Bonomi, M., Camilloni, C., Simone, A. D., & Vendruscolo, M. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.07.016 · Cited by 64 · see citing works

Methods of probing the interactions between small molecules and disordered proteins

Heller, G. T., Aprile, F. A., & Vendruscolo, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2563-4 · Cited by 62 · see citing works

Insights into protein misfolding and aggregation enabled by solid-state NMR spectroscopy

van der Wel, P. C. A. (2017) · Solid State Nuclear Magnetic Resonance · doi:10.1016/j.ssnmr.2017.10.001 · Cited by 64 · see citing works

Identification of Small Molecule Inhibitors of Tau Aggregation by Targeting Monomeric Tau As a Potential Therapeutic Approach for Tauopathies

Pickhardt, M., Neumann, T., Schwizer, D., Callaway, K., Vendruscolo, M., Schenk, D., George‐Hyslop, P. S., Mandelkow, E., Dobson, C. M., McConlogue, L., et al. (2015) · Current Alzheimer Research · doi:10.2174/156720501209151019104951 · Cited by 63 · see citing works

Structural Ensemble Modulation upon Small-Molecule Binding to Disordered Proteins

Heller, G. T., Bonomi, M., & Vendruscolo, M. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.03.015 · Cited by 61 · see citing works

Hsp70 chaperone blocks α-synuclein oligomer formation via a novel engagement mechanism

Tao, J., Berthet, A., Citron, Y. R., Tsiolaki, P. L., Stanley, R. F., Gestwicki, J. E., Agard, D. A., & McConlogue, L. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100613 · Cited by 58 · see citing works

Alpha-synuclein, Proteotoxicity and Parkinson's Disease: Search for Neuroprotective Therapy

Ganguly, U., Chakrabarti, S. S., Kaur, U., Mukherjee, A., & Chakrabarti, S. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666171129100944 · Cited by 56 · see citing works

Computational strategy for intrinsically disordered protein ligand design leads to the discovery of p53 transactivation domain I binding compounds that activate the p53 pathway

Ruan, H., Chen, Y., Niu, X., Zhang, W., Liu, H., Chen, L., Xiong, R., Sun, Q., Jin, C., Liu, Y., et al. (2020) · Chemical Science · doi:10.1039/d0sc04670a · Cited by 55 · see citing works

A Small Molecule Causes a Population Shift in the Conformational Landscape of an Intrinsically Disordered Protein

Ban, D., Iconaru, L. I., Ramanathan, A., Zuo, J., & Kriwacki, R. W. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b01380 · Cited by 55 · see citing works

Targeting Intrinsically Disordered Proteins through Dynamic Interactions

Chen, J., Liu, X., & Chen, J. (2020) · Biomolecules · doi:10.3390/biom10050743 · Cited by 54 · see citing works

A Small Molecule Stabilizes the Disordered Native State of the Alzheimer’s Aβ Peptide

Löhr, T., Kohlhoff, K. J., Heller, G. T., Camilloni, C., & Vendruscolo, M. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00116 · Cited by 50 · see citing works

Parkinson’s Disease: Exploring Different Animal Model Systems

Khan, E., Hasan, I., & Haque, M. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24109088 · Cited by 53 · see citing works

Binding cavities and druggability of intrinsically disordered proteins

Zhang, Y., Cao, H., & Liu, Z. (2015) · Protein Science · doi:10.1002/pro.2641 · Cited by 51 · see citing works

Small Molecules Detected by Second-Harmonic Generation Modulate the Conformation of Monomeric α-Synuclein and Reduce Its Aggregation in Cells

Moree, B., Yin, G., Lázaro, D. F., Munari, F., Strohäker, T., Giller, K., Becker, S., Outeiro, T. F., Zweckstetter, M., & Salafsky, J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.636027 · Cited by 48 · see citing works

Transient disorder along pathways to amyloid

Morgan, G. J. (2021) · Biophysical Chemistry · doi:10.1016/j.bpc.2021.106711 · Cited by 47 · see citing works

Combating neurodegenerative disease with chemical probes and model systems

Narayan, P. S., Ehsani, S., & Lindquist, S. L. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1663 · Cited by 46 · see citing works

Development and Application of a Sensitive Peptide Reporter to Discover 20S Proteasome Stimulators

Coleman, R. A., & Trader, D. J. (2018) · ACS Combinatorial Science · doi:10.1021/acscombsci.7b00193 · Cited by 45 · see citing works

The Aggregation Conditions Define Whether EGCG is an Inhibitor or Enhancer of α-Synuclein Amyloid Fibril Formation

Sternke‐Hoffmann, R., Peduzzo, A., Bolakhrif, N., Haas, R. R., & Buell, A. K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21061995 · Cited by 50 · see citing works

Ramachandran mapping of peptide conformation using a large database of computed Raman and Raman optical activity spectra

Mensch, C., Barron, L. D., & Johannessen, C. (2016) · Physical Chemistry Chemical Physics · doi:10.1039/c6cp05862k · Cited by 44 · see citing works

A Fragment-Based Method of Creating Small-Molecule Libraries to Target the Aggregation of Intrinsically Disordered Proteins

Joshi, P., Chia, S., Habchi, J., Knowles, T. P. J., Dobson, C. M., & Vendruscolo, M. (2016) · ACS Combinatorial Science · doi:10.1021/acscombsci.5b00129 · Cited by 43 · see citing works

Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form

Collier, T. J., Srivastava, K. R., Justman, C. J., Grammatopoulous, T., Hutter‐Paier, B., Prokesch, M., Havas, D., Rochet, J., Liu, F., Jock, K., et al. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.07.007 · Cited by 41 · see citing works

Dynamic conformational flexibility and molecular interactions of intrinsically disordered proteins

Bhattarai, A., & Emerson, I. A. (2020) · Journal of Biosciences · doi:10.1007/s12038-020-0010-4 · Cited by 39 · see citing works

Targeting protein disorder: the next hurdle in drug discovery

Lázár, T., Connor, A., DeLisle, C. F., Burger, V., & Tompa, P. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01220-6 · Cited by 43 · see citing works

Raman optical activity of human α‐synuclein in intrinsically disordered, micelle‐bound α‐helical, molten globule and oligomeric β‐sheet state

Mensch, C., Konijnenberg, A., Elzen, R. V., Lambeir, A., Sobott, F., & Johannessen, C. (2017) · Journal of Raman Spectroscopy · doi:10.1002/jrs.5149 · Cited by 39 · see citing works

Rational drug design targeting intrinsically disordered proteins

Wang, H., Xiong, R., & Lai, L. (2023) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1685 · Cited by 39 · see citing works

iPS cells in the study of PD molecular pathogenesis

Cobb, M. M., Ravisankar, A., Skibinski, G., & Finkbeiner, S. M. (2017) · Cell and Tissue Research · doi:10.1007/s00441-017-2749-y · Cited by 35 · see citing works

p27Kip1, an Intrinsically Unstructured Protein with Scaffold Properties

Bencivenga, D., Stampone, E., Roberti, D., Ragione, F. D., & Borriello, A. (2021) · Cells · doi:10.3390/cells10092254 · Cited by 37 · see citing works

Structural Basis of Small Molecule Targetability of Monomeric Tau Protein

Kiss, R., Csizmadia, G., Solti, K., Keresztes, A., Zhu, M., Pickhardt, M., Mandelkow�, E., & Tóth, G. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00182 · Cited by 36 · see citing works

Amphipathic helical peptides hamper protein-protein interactions of the intrinsically disordered chromatin nuclear protein 1 (NUPR1)

Santofimia‐Castaño, P., Rizzuti, B., Abián, O., Velázquez‐Campoy, A., Iovanna, J., & Neira, J. L. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.03.009 · Cited by 33 · see citing works

The Rational Discovery of a Tau Aggregation Inhibitor

Baggett, D. W., & Nath, A. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00581 · Cited by 34 · see citing works

Intrinsically Disordered Proteins

Uversky, V. N. (2020) · Wiley eBooks · doi:10.1002/9781118681121.ch25 · Cited by 32 · see citing works

Structure-based peptide design targeting intrinsically disordered proteins: Novel histone H4 and H2A peptidic inhibitors

Wichapong, K., Silvestre-Roig, C., Braster, Q., Schumski, A., Soehnlein, O., & Nicolaes, G. A. F. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.01.026 · Cited by 32 · see citing works

Resolving the Atomistic Modes of Anle138b Inhibitory Action on Peptide Oligomer Formation

Matthes, D., Gapsys, V., Griesinger, C., & de Groot, B. L. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00325 · Cited by 32 · see citing works

Small Molecule Sequestration of the Intrinsically Disordered Protein, p27Kip1, Within Soluble Oligomers

Iconaru, L. I., Das, S., Nourse, A., Shelat, A. A., Zuo, J., & Kriwacki, R. W. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167120 · Cited by 30 · see citing works

Antibodies against the C-terminus of α-synuclein modulate its fibrillation

Sahin, C., Lorenzen, N., Lemminger, L., Christiansen, G., Møller, I. M., Vesterager, L. B., Pedersen, L. Ø., Fog, K., Kallunki, P., & Otzen, D. E. (2016) · Biophysical Chemistry · doi:10.1016/j.bpc.2016.11.002 · Cited by 30 · see citing works

Structural Effects of Two Camelid Nanobodies Directed to Distinct C-Terminal Epitopes on α-Synuclein

El-Turk, F., Newby, F. N., Genst, E. D., Guilliams, T., Sprules, T. J., Mittermaier, A., Dobson, C. M., & Vendruscolo, M. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00149 · Cited by 29 · see citing works

Patient-Derived Induced Pluripotent Stem Cell-Based Models in Parkinson’s Disease for Drug Identification

Kouroupi, G., Antoniou, N., Prodromidou, K., Taoufik, E., & Matsas, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197113 · Cited by 29 · see citing works

Intracellular Alpha-Synuclein and Immune Cell Function

Grozdanov, V., & Danzer, K. M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.562692 · Cited by 27 · see citing works

Multi-Pronged Interactions Underlie Inhibition of α-Synuclein Aggregation by β-Synuclein

Williams, J. K., Yang, X., Atieh, T. B., Olson, M. P., Khare, S. D., & Baum, J. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.05.024 · Cited by 27 · see citing works

β-asarone increases MEF2D and TH levels and reduces α-synuclein level in 6-OHDA-induced rats via regulating the HSP70/MAPK/MEF2D/Beclin-1 pathway: Chaperone-mediated autophagy activation, macroautophagy inhibition and HSP70 up-expression

Huang, L., Deng, M., He, Y., Lu, S. Y., Liu, S., & Fang, Y. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.07.028 · Cited by 27 · see citing works

Interactions between the Intrinsically Disordered Proteins β‐Synuclein and α‐Synuclein

Williams, J. K., Yang, X., & Baum, J. (2018) · PROTEOMICS · doi:10.1002/pmic.201800109 · Cited by 26 · see citing works

Comparative Studies in the A30P and A53T α-Synuclein C. elegans Strains to Investigate the Molecular Origins of Parkinson's Disease

Perni, M., van der Goot, A., Limbocker, R., van Ham, T. J., Aprile, F. A., Xu, C. K., Flagmeier, P., Thijssen, K. L., Sormanni, P., Fusco, G., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.552549 · Cited by 25 · see citing works

Non-covalent S⋯O interactions control conformation in a scaffold that disrupts islet amyloid polypeptide fibrillation

Peacock, H., Luo, J., Yamashita, T., Luccarelli, J., Thompson, S., & Hamilton, A. D. (2016) · Chemical Science · doi:10.1039/c6sc00756b · Cited by 26 · see citing works

Challenging drug target for Parkinson's disease: Pathological complex of the chameleon TPPP/p25 and alpha-synuclein proteins

Szénási, T., Oláh, J., Szabó, A., Szunyogh, S., Láng, A., Perczel, A., Lehotzky, A., Uversky, V. N., & Ovádi, J. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.09.017 · Cited by 26 · see citing works

Novel Small Molecules Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein Protect Against Diverse α-Synuclein Mediated Dysfunctions

Tóth, G., Neumann, T., Berthet, A., Masliah, E., Spencer, B. J., Tao, J., Jobling, M. F., Gardai, S. J., Bertoncini, C. W., Cremades, N., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-52598-4 · Cited by 26 · see citing works

Interactions between Microtubule-Associated Protein Tau (MAPT) and Small MoleculesPreprint

Rauch, J. N., Olson, S. H., & Gestwicki, J. E. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024034 · Cited by 22 · see citing works

Emerging preclinical pharmacological targets for Parkinson's disease

More, S. V., & Choi, D. (2016) · Oncotarget · doi:10.18632/oncotarget.8104 · Cited by 23 · see citing works

What can trigger the onset of Parkinson's disease – A modeling study based on a compartmental model of α-synuclein transport and aggregation in neurons

Kuznetsov, I. A., & Kuznetsov, A. V. (2016) · Mathematical Biosciences · doi:10.1016/j.mbs.2016.05.002 · Cited by 21 · see citing works

Role of the microtubule-associated TPPP/p25 in Parkinson’s and related diseases and its therapeutic potential

Oláh, J., Bertrand, P., & Ovádi, J. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1304216 · Cited by 20 · see citing works

A RaPID Macrocyclic Peptide That Inhibits the Formation of α‐Synuclein Amyloid Fibrils

Ikenoue, T., Oono, M., So, M., Yamakado, H., Arata, T., Takahashi, R., Kawata, Y., & Suga, H. (2023) · ChemBioChem · doi:10.1002/cbic.202300320 · Cited by 21 · see citing works

Targeting α-synuclein as a therapeutic strategy for Parkinson’s disease

Lawand, N., Saadé, N. E., El‐Agnaf, O. M. A., & Safieh‐Garabedian, B. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1062877 · Cited by 19 · see citing works

13C APSY-NMR for sequential assignment of intrinsically disordered proteins

Murrali, M. G., Schiavina, M., Sainati, V., Bermel, W., Pierattelli, R., & Felli, I. C. (2018) · Journal of Biomolecular NMR · doi:10.1007/s10858-018-0167-4 · Cited by 19 · see citing works

The Role of Astrocytes and Alpha-Synuclein in Parkinson’s Disease: A Review

Brash-Arias, D., García, L. I., Pérez-Estudillo, C. A., Rojas-Durán, F., Aranda-Abreu, G. E., Herrera‐Covarrubias, D., & Chi-Castañeda, D. (2024) · NeuroSci · doi:10.3390/neurosci5010005 · Cited by 18 · see citing works

α‐Synuclein Oligomers: A Study in Diversity

van Diggelen, F., Tepper, A. W. J. W., Apetri, M. M., & Otzen, D. E. (2016) · Israel Journal of Chemistry · doi:10.1002/ijch.201600116 · Cited by 18 · see citing works

Perspectives on evolutionary and functional importance of intrinsically disordered proteins

Handa, T., Kundu, D., & Dubey, V. K. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.10.120 · Cited by 17 · see citing works

How to drug a cloud? Targeting intrinsically disordered proteins

Uversky, V. N. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.001113 · Cited by 17 · see citing works

Targeting the Intrinsically Disordered Proteome Using Small-Molecule Ligands

Wojcik, S. P., Birol, M., Rhoades, E. R., Miranker, A. D., & Levine, Z. A. (2018) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2018.09.036 · Cited by 17 · see citing works

Thermodynamic and kinetic approaches for drug discovery to target protein misfolding and aggregation

Vendruscolo, M. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2221024 · Cited by 15 · see citing works

Conformational Disorder and Dynamics of Proteins Sensed by Raman Optical Activity

Mensch, C., Bultinck, P., & Johannessen, C. (2018) · ACS Omega · doi:10.1021/acsomega.8b01955 · Cited by 15 · see citing works

Pharmacological targeting of α‐synuclein and TPPP /p25 in Parkinson's disease: challenges and opportunities in a Nutshell

Oláh, J., & Ovádi, J. (2019) · FEBS Letters · doi:10.1002/1873-3468.13464 · Cited by 14 · see citing works

Characterization of the Binding of Small Molecules to Intrinsically Disordered Proteins

Dobrev, V. S., Fred, L. M., Gerhart, K. P., & Metallo, S. J. (2018) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2018.09.033 · Cited by 14 · see citing works

Barriers to Small Molecule Drug Discovery for Systemic Amyloidosis

Morgan, G. (2021) · Molecules · doi:10.3390/molecules26123571 · Cited by 11 · see citing works

Hitting on the move: targeting intrinsically disordered protein states of the MDM2-p53 interaction

Neochoritis, C. G., Atmaj, J., Twarda-Clapa, A., Surmiak, E., Skalniak, L., Köhler, L.-M., Muszak, D., Kurpiewska, K., Kalinowska-Tłuścik, J., Beck, B., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111588 · Cited by 12 · see citing works

Unraveling the Behavior of Intrinsically Disordered Protein c-Myc: A Study Utilizing Gaussian-Accelerated Molecular Dynamics

Gunasinghe, K. K. J., Rahman, T., & Wezen, X. C. (2023) · ACS Omega · doi:10.1021/acsomega.3c05822 · Cited by 11 · see citing works

Structure-Based Small Molecule Modulation of a Pre-Amyloid State: Pharmacological Enhancement of IAPP Membrane-Binding and Toxicity

Nath, A., Schlamadinger, D. E., Rhoades, E. R., & Miranker, A. D. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00052 · Cited by 11 · see citing works

An update on potential therapeutic strategies for Parkinson’s disease based on pathogenic mechanisms

Shen, T., Pu, J., Si, X., Ye, R., & Zhang, B. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1179112 · Cited by 11 · see citing works

Perspectives on drug discovery strategies based on IDPs

Fuertes, G., Nevola, L., & Esteban-Martín, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816348-1.00009-0 · Cited by 11 · see citing works

Chemical tools for study and modulation of biomolecular phase transitions

Berkeley, R. F., & Debelouchina, G. T. (2022) · Chemical Science · doi:10.1039/d2sc04907d · Cited by 11 · see citing works

Targeting the Intrinsically Disordered Structural Ensemble of a-Synuclein by Small Molecules as a Potential Therapeutic Strategy for Parkinson’s Disease

Gardai, S. J., Zago, W. M., Bertoncini, C. W., Cremades, N., Roy, S. L., Tambe, M. A., Rochet, J.-C., Galvagnion, C., Skibinski, G., Finkbeiner, S., et al. (2016)

Novel Small Molecules Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein Protect Against Diverse α-Synuclein Mediated Dysfunctions.

Tóth, G., Neumann, T., Berthet, A., Masliah, E., Spencer, B. J., Tao, J., Jobling, M. F., Gardai, S. J., Bertoncini, C. W., Cremades, N., et al. (2019) · Apollo (University of Cambridge) · doi:10.17863/cam.47311

Targeting the Intrinsically Disordered Structural Ensemble of alpha-Synuclein by Small Molecules as a Potential Therapeutic Strategy for Parkinson's Disease

Toth, G., Gardai, S., Zago, W., Bertoncini, C., Cremades, N., Roy, S., Tambe, M., Rochet, J.-C., Galvagnion, C., Skibinski, G., et al. (2014) · UCL Discovery (University College London) · Cited by 1 · see citing works

Synthetic strategies for small molecule compounds for the treatment of Parkinson’s disease: targeting α-synuclein

Ai, B., Zhang, X.-Y., Hu, C., Guo, Z., & Jin, C.-H. (2026) · Molecular Diversity · doi:10.1007/s11030-026-11510-9

Targeting α-Synuclein as a Parkinson’s Disease Therapeutic

Esposito, L. (2014) · Topics in medicinal chemistry · doi:10.1007/7355_2014_66